Sovenyr Get early access

Signal2026-06-26

PubMed

Progress in engineered bacterial cancer therapies.

Part of

Innovative Biologic Cancer Therapeutics

Open primary source See the whole picture

Powered by Sovenyr — cross-source signal intelligence. Figures are collected data as-dated, not investment advice.